Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Teva
McKesson
Johnson and Johnson
QuintilesIMS
Chinese Patent Office
Chubb
Federal Trade Commission
Queensland Health
Boehringer Ingelheim

Generated: August 20, 2017

DrugPatentWatch Database Preview

DEPO-MEDROL Drug Profile

« Back to Dashboard

Which patents cover Depo-medrol, and when can generic versions of Depo-medrol launch?

Depo-medrol is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in DEPO-MEDROL is methylprednisolone acetate. There are forty drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.

Summary for Tradename: DEPO-MEDROL

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list10
Bulk Api Vendors: see list17
Clinical Trials: see list70
Patent Applications: see list2,208
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DEPO-MEDROL at DailyMed

Pharmacology for Tradename: DEPO-MEDROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
DEPO-MEDROL
methylprednisolone acetate
INJECTABLE;INJECTION011757-002Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
DEPO-MEDROL
methylprednisolone acetate
INJECTABLE;INJECTION011757-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
DEPO-MEDROL
methylprednisolone acetate
INJECTABLE;INJECTION011757-004Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Merck
Fish and Richardson
Argus Health
Boehringer Ingelheim
Medtronic
Citi
Queensland Health
Chinese Patent Office
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot